West Chester, Pennsylvania, Molecular Targeting Technologies, Inc., (MTTI) announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D., Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.. Dr. Scott Hilderbrand, Principal Investigator at Massachusetts General Hospital and Harvard Medical School said, “Due to the […]

MORRIS TOWNSHIP, N.J. – Honeywell (NYSE:HON) announced today the introduction of a new RNA reagent for use in developing advanced therapeutic medicines. The new product, the Burdick & Jackson rBMI activator, is designed to help laboratories reduce the use of costly amidites, critical ingredients used in the process of making RNA-based medicines, without reducing RNA […]

VICTORIA, British Columbia ? GenoLogics, a leading provider of laboratory information management system (LIMS) software specifically designed for next-generation genomics labs, today announced the release of a pre-configured version of its LIMS software for Illumina (NASDAQ:ILMN) next-generation sequencing (NGS) systems and TruSeq Sample Prep Kits. The pre-configured GenoLogics LIMS software significantly speeds implementation time for […]

Uppsala, Sweden – Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that sales are showing a positive trend similar to that seen throughout 2010. Major biopharmaceutical companies continued to demonstrate their confidence in the Gyros immunoassay platform, with existing accounts investing in additional Gyrolab™ workstations at different […]

In a recent study (1), Rakhilin et al. used the xCELLigence system from Roche (SIX: RO, ROG; OTCQX: RHHBY) as a novel method to evaluate changes in myotube thickness via measuring cellular electrical impedance. They showed that both qualitative and quantitative changes in electrical impedance as a function of cellular adhesion in real time correlate […]

BRISBANE, Australia – Mincom today announced that its strong enterprise software business is well positioned for the next phase of growth with the support of its new owner, ABB– one of the world’s leading global power and automation technology companies. ABB is acquiring Mincom from private equity group Francisco Partners to broaden its software portfolio […]

BERLIN and BURLINGTON, Mass. – caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry (CCMS) platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million ($1.4 M) to its Series B financing, increasing total equity for the round to […]

De Novo Software™, a leading provider of flow and image cytometry data analysis solutions, and Molecular Devices, a provider of premiere bioresearch and drug discovery systems, announced today a licensing agreement enabling Molecular Devices to distribute De Novo Software’s flagship product, FCS Express 4 Software. This supports full compatibility with the ImageXpress Velos® Cytometer (formerly […]

SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced the availability of assays and primers optimized for the company’s integrated fluidic circuit technology. Fluidigm Assays and Target-specific Primers will provide customers with significantly lower costs than today’s standard solutions, at volumes appropriate for microfluidics, and flexible chemistries so that customers can easily create highly […]

SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip® Microarray Instrument System for in vitro diagnostic (IVD) use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic […]